Efficacy and safety of once‐weekly versus once‐daily basal insulin analogues in the treatment of type 2 diabetes mellitus: A systematic review and meta‐analysis
Diabetes Obesity and Metabolism2023Vol. 25(12), pp. 3648–3661
Citations Over TimeTop 10% of 2023 papers
Paschalis Karakasis, Dimitrios Patoulias, Konstantinos Pamporis, Djordje S. Popovic, Panagiotis Stachteas, Konstantinos I. Bougioukas, Nikolaos Fragakis, Manfredi Rizzo
Abstract
The once-weekly basal insulin analogues seem to be at least equally efficient in glycaemic management and safe compared to once-daily injections in people with T2DM. Phase 4 RCTs are expected to shed further light on the effectiveness and safety of once-weekly insulin therapy over the long term.
Related Papers
- → A Comparison of Clinical Follow-Up of Different Total Temporomandibular Joint Replacement Prostheses: A Systematic Review and Meta-Analysis(2017)75 cited
- → Empirical comparison of subgroup effects in conventional and individual patient data meta-analyses(2008)48 cited
- → The effects of chromium supplementation on blood pressure: a systematic review and meta-analysis of randomized clinical trials(2021)8 cited
- MiR-146a rs2910164 polymorphism is associated with hepatocellular carcinoma: a meta-analysis.(2015)
- → Network Meta-Analysis of the Antihypertensive Effect of Traditional Chinese Exercises on Patients with Essential Hypertension(2022)6 cited